Form 4 for LSTA LISATA THERAPEUTICS, INC.
Accepted 2024-01-12 00:00:00 ET · period of report 2024-01-11 · accession 0001334549-24-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-12 | 2024-01-11 | LSTA | Mazzo David J | CEO, Dir | F - Tax | $2.99 | -1,026 | 174.8K | -0.6% | -$3,068 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-11 | F | D | 1,026 | $2.99 | 174,766 | D | — | — | (F1) Shares withheld as payment of a tax liability on vesting of restricted stock. (F2) Includes 107,183 unvested restricted stock. |